Hypoalbuminemia predicts inferior outcome in patients with AIDS-related lymphoma
Abstract Background The prognostic value of serum albumin in acquired immunodeficiency syndrome (AIDS)-related lymphoma (ARL) remains covered. Methods We retrospectively analyzed de novo ARL patients from 2013 to 2019 across three centers. Factors correlated with progression-free survival (PFS) and...
Saved in:
Published in | Infectious agents and cancer Vol. 17; no. 1; pp. 1 - 33 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
18.06.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Background
The prognostic value of serum albumin in acquired immunodeficiency syndrome (AIDS)-related lymphoma (ARL) remains covered.
Methods
We retrospectively analyzed de novo ARL patients from 2013 to 2019 across three centers. Factors correlated with progression-free survival (PFS) and overall survival (OS) were evaluated in Kaplan–Meier, univariate and multivariate Cox proportional hazard models.
Results
A total of 86 ARL patients were enrolled with a median follow-up of 34 months. In the cohort, the OS and 2-year PFS rates were 37.5% and 35.4%, respectively. In multivariate models, older age (PFS, hazard ratios [HR] = 1.035,
p
= 0.037; OS, HR = 1.034,
p
= 0.041) and hypoalbuminemia (OS, HR = 0.910,
p
= 0.038) predicted inferior survival. ARL patients with hypoalbuminemia showed worse OS and 2-year PFS (
p
= 0.028 and
p
= 0.01, respectively), which was associated with poor Eastern Cooperative Oncology Group performance status (ECOG PS) and higher International Prognosis Index (IPI) score.
Conclusion
In conclusion, serum albumin at diagnosis is an independent prognostic factor for overall survival in AIDS-related lymphoma. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1750-9378 1750-9378 |
DOI: | 10.1186/s13027-022-00448-w |